Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.

Lin Y, Ukaji T, Koide N, Umezawa K.

Int J Mol Sci. 2018 Mar 3;19(3). pii: E729. doi: 10.3390/ijms19030729. Review.

2.

Inhibition of MMP-2-mediated cellular invasion by NF-κB inhibitor DHMEQ in 3D culture of breast carcinoma MDA-MB-231 cells: A model for early phase of metastasis.

Ukaji T, Lin Y, Okada S, Umezawa K.

Biochem Biophys Res Commun. 2017 Mar 25;485(1):76-81. doi: 10.1016/j.bbrc.2017.02.022. Epub 2017 Feb 8.

PMID:
28188787
3.

Inhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma Cells.

Ukaji T, Lin Y, Banno K, Okada S, Umezawa K.

PLoS One. 2015 Sep 11;10(9):e0137663. doi: 10.1371/journal.pone.0137663. eCollection 2015.

4.

Novel approaches to target NF-κB and other signaling pathways in cancer stem cells.

Ukaji T, Umezawa K.

Adv Biol Regul. 2014 Sep;56:108-15. doi: 10.1016/j.jbior.2014.06.001. Epub 2014 Jul 1. Review.

PMID:
25128192
5.

Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.

Koide N, Kondo Y, Odkhuu E, Ulziisaikhan J, Ukaji T, Yokochi T, Umezawa K.

Immunol Lett. 2014 Sep;161(1):31-7. doi: 10.1016/j.imlet.2014.04.006. Epub 2014 May 2.

PMID:
24792671
6.

Involvement of conserved tryptophan residues for secretion of TIMP-2.

Ukaji T, Sasazawa Y, Umezawa K, Simizu S.

Oncol Lett. 2014 Mar;7(3):631-634. Epub 2013 Dec 23.

7.

Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp.

Arai Y, Iinuma H, Ikeda Y, Igarashi M, Hatano M, Kinoshita N, Ukaji T, Simizu S, Umezawa K.

J Antibiot (Tokyo). 2013 Apr;66(4):225-30. doi: 10.1038/ja.2012.112. Epub 2012 Dec 12.

PMID:
23232932

Supplemental Content

Loading ...
Support Center